http://www.fda.gov/bbs/topics/ANSWERS/2004/ANS01336.html
U.S. Food and Drug Administration
The Food and Drug Administration (FDA) today issued a Public Health Advisory summarizing the agency's recent recommendations concerning the use of non-steroidal anti-inflammatory drug products (NSAIDs), including those known as COX-2 selective agents. The public health advisory is an interim measure, pending further review of data that continue to be collected.